Number unique A-genes | 9 |
---|---|
Number unique B-genes | 3141 |
Number unique A-B gene pairs | 4374 |
Total number of interactions | 36109 |
A-argument | B-argument | count |
---|---|---|
AMPK | STK11 | 1275 |
AMPK | MTOR | 1176 |
AMPK | ULK1 | 1026 |
AMPK | SIRT1 | 950 |
AMPK | ADIPOQ | 948 |
AMPK | PPARGC1A | 812 |
AMPK | ATIC | 630 |
AMPK | TP53 | 503 |
AMPK | AKT | 484 |
AMPK | CAMKK2 | 427 |
input | recognized symbol | mapping type |
---|---|---|
fplx:AMPK | AMPK | FamPlex Concept |
input | recognized symbol | mapping type |
---|---|---|
fplx:AMPK | AMPK | FamPlex Concept |
input | recognized symbol | mapping type |
---|
Gene A Symbol | Gene B Symbol | Gene A Gene ID | Gene B Gene ID | Relation Types | Factuality | Fulltext Match Source | Document ID | Context |
---|---|---|---|---|---|---|---|---|
AMPK | LEP | FPLX:AMPK | 3952 | Negative_regulation, Positive_regulation | none | 22327423 | Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells. | |
AMPK | SHMT2 | FPLX:AMPK | 6472 | Phosphorylation, Positive_regulation | none | 31167694 | Conclusion SHMT2 may induce autophagy by promoting AMPK phosphorylation and directly or indirectly inhibiting mTOR activity, thus leading to chemotherapy-induced apoptosis tolerance and resistance to chemotherapeutics. | |
AMPK | ATM | FPLX:AMPK | 472 | Positive_regulation | none | 29405820 | Neratinib and niraparib caused the ATM-dependent activation of AMPK which in turn was required to cause mTOR inactivation, ULK-1 activation and ATG13 phosphorylation. | |
AMPK | SAG | FPLX:AMPK | 6295 | Positive_regulation | none | 25582777 | Moreover, SAG induced a profound AMP-activated protein kinase (AMPK) activation, and then directly phosphorylated and activated the downstream autophagy initiator Ulk1, independent of the autophagy suppressor mammalian target of rapamycin (mTOR) complex 1. | |
AMPK | ATIC | FPLX:AMPK | 471 | Positive_regulation | none | 20664053 | AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells. | |
AMPK | STK11 | FPLX:AMPK | 6794 | Positive_regulation | none | 20615625 | IR induced a robust phosphorylation and activation of AMPK in all tumor cells, independent of LKB1. | |
AMPK | nedd4l.S | FPLX:AMPK | 399396 | Negative_regulation, Positive_regulation | none | 23221389 | AMPK inhibits Kv1.5 presumably in part by activation of Nedd4- 2 with subsequent clearance of channel protein from the cell membrane. | |
AMPK | STK11 | FPLX:AMPK | 6794 | Positive_regulation | none | 26398719 | LKB1 phosphorylates and activates AMP-activated protein kinase (AMPK), which negatively regulates cancer cell proliferation and metabolism. | |
AMPK | PRKAA1 | FPLX:AMPK | 5562 | Phosphorylation, Negative_regulation | none | 29089333 | EPS stimulated AMPK and CaMKII phosphorylation, and EPS-stimulated GLUT4 translocation was reduced in part by small interfering (si)RNA-mediated AMPKα1/α2 knockdown, compound C, siRNA-mediated Ca2+/calmodulin-dependent protein kinase (CaMKII)δ knockdown, or CaMKII inhibitor KN93. | |
AMPK | BTN2A1 | FPLX:AMPK | 11120 | Positive_regulation | none | 37648854 | This induction of both BTN3A and BTN2A1 during metabolic crises is dependent on AMP-activated protein kinase (AMPK). |
Interaction data is being assembled. This may take a while depending on result size and server load. You can use the link below to fetch the download at a later time. The link is valid at least 24h.